|
ZNF718 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.191520E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.635860E-03 |
| Normal-vs-Stage2 |
6.796600E-01 |
| Normal-vs-Stage3 |
4.757200E-01 |
| Normal-vs-Stage4 |
4.074200E-01 |
| Stage1-vs-Stage2 |
2.204000E-01 |
| Stage1-vs-Stage3 |
2.916800E-01 |
| Stage1-vs-Stage4 |
8.058800E-01 |
| Stage2-vs-Stage3 |
8.361000E-01 |
| Stage2-vs-Stage4 |
6.065200E-01 |
| Stage3-vs-Stage4 |
7.303000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.339200E-03 |
| Normal-vs-AfricanAmerican |
2.657600E-01 |
| Normal-vs-Asian |
3.066000E-01 |
| Caucasian-vs-AfricanAmerican |
4.417600E-01 |
| Caucasian-vs-Asian |
7.201000E-01 |
| AfricanAmerican-vs-Asian |
5.672400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.876100E-03 |
| Normal-vs-Female |
1.523410E-01 |
| Male-vs-Female |
5.193600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.812360E-02 |
| Normal-vs-Extreme_Weight |
2.22930000000066E-05 |
| Normal-vs-Obese |
9.537800E-01 |
| Normal-vs-Extreme_Obese |
3.069600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.981800E-01 |
| Normal_Weight-vs-Obese |
5.128400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.167400E-01 |
| Extreme_Weight-vs-Obese |
9.985700E-04 |
| Extreme_Weight-vs-Extreme_Obese |
3.879800E-01 |
| Obese-vs-Extreme_Obese |
3.683200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.123600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.238600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.820000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.854000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.097600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.820400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.200600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.620000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.675170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.005750E-02 |
| Normal-VS-Type2 PRCC |
1.080590E-01 |
| Normal-VS-KIRP CIMP |
1.182850E-01 |
| Normal-VS-Unclassified PRCC |
5.254200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.572800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.804600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.635400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.833200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.844600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.231800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.43059999999184E-05 |
| Normal-vs-N1 |
4.490200E-01 |
| Normal-vs-N2 |
3.219900E-04 |
| N0-vs-N1 |
1.214430E-02 |
| N0-vs-N2 |
2.691200E-01 |
| N1-vs-N2 |
1.762700E-03 |
|
|
